Posts Tagged ‘pharmaceutical stocks’

CABB jumps, SGAMY trades widely, ABPI sinks after Chapter 11

Thursday, November 18th, 2010

California Business Bank (OTCBB: CABB) gained 28.89 percent in Thursday afternoon trading to $2.90. Volume was 1,100 shares, easily surpassing its 3-month daily average volume of 488.

Sega Sammy Holdings Inc Sponsored ADR (Pink Sheets: SGAMY) was among the volume leaders in micro-caps Thursday afternoon, with 5,209,257 shares changing hands, more than 15-times its average volume of 333,776. The stock gained 4.48 percent in price to $4.20.

Accentia Biopharmaceuticals Inc. (Pink Sheets: ABPI) lost 1.02 percent in price Thursday afternoon to 97 cents. Volume was 289,330 shares. ABPI announced Wednesday that the Company and its majority-owned subsidiary, Biovest International, Inc. have both successfully completed their reorganizations. Pursuant to their respective Plans of Reorganization approved by the bankruptcy court, Accentia and Biovest have now formally exited Chapter 11 as fully restructured organizations.

CHS chugs along, INTC among volume kings, TKMR thumped

Wednesday, November 17th, 2010

Chico’s Fas, Inc. (NYSE: CHS) prospered 9.41 percent in price Wednesday to $11.02. Volume was 10,782,229 shares, more than doubling its daily average of 4,519,330. CHS, based in Fort Myers, Fla., Wednesday reported third-quarter net income of $28.8 million, or $0.16 per diluted share, for the third quarter compared to net income of $22.7 million, or $0.13 per diluted share, for last year’s third quarter.

Intel Inc. (NasdaqGS: INTC) had an active Wednesday, trading in 33,245,903 shares, though less than half of its three-month daily average of 68,021,700. The software giant’s shares lost 0.28 percent worth of steam in Wednesday trading to $21.01 just half an hour before the closing bell. INTC announced Wednesday that it has inked a letter of intent with China’s homegrown auto electronics enterprise Hangsheng to jointly set up an auto electronics laboratory,

Tekmira Pharmaceuticals Inc. (NasdaqCM: TKMR) fell in price Wednesday afternoon by 17.02 percent to $5.80. Its volume of 34,300 shares was still nearly double TKMR’s three-month daily average. The Vancouver-based in RNA interference therapeutics announced Monday third-quarter financials, featuring net loss of $2.7 million ($0.26 per common share) as compared to a net loss of $2.8 million ($0.27 per common share) for Q3 2009.

KV surges, BAC trades, JTX swoons

Wednesday, November 17th, 2010

KV Pharmaceutical CLA (NYSE: KV-A) increased 14.69 percent in price Wednesday to $2.42. Volume was 480,021 shares, rapidly catching up on its daily average of 548,417. The St. Louis-based KV announced today that it has entered into an agreement with US Healthcare I, L.L.C. and US Healthcare II, L.L. C. affiliates of New York-based Centerbridge Partners, L.P for a senior secured debt financing package of up to $120 million.

Bank of America Corp. (NYSE: BAC) was a volume leader Wednesday, dealing in 71,100,577shares, compared to its three-month daily average of 196,016,000. The carmaker saw its stock price skid 1.63 percent to $11.74. BAC was ordered by a U.S. judge to return $500 million of deposits it seized from Lehman Brothers Holdings Inc shortly after Lehman’s record bankruptcy.

Jackson Hewitt Tax Service Inc. (NYSE: JTX) fell in price by noon Wednesday by 18.88 percent to 82.74 cents. Volume was 1,954,063 shares, more than four times its three-month daily average.

PRPH points higher, F rolls off lot, AH ailing

Thursday, November 11th, 2010

ProPhase Labs Inc. (NasdaqGM: PRPH) charged ahead in early afternoon trading Thursday, gaining 32.69 percent to $1.38. Volume was 25,509 shares, or more than four times its daily average. The drug company, based in Doylestown, Pa., Wednesday reported quarterly net sales of $5.20 million for the three months ended September 30, 2010, compared to net sales of $4.98 million for the prior-year quarter. PRPH realized quarterly net income of $947,000, or $0.06 per share, compared to net income of $1.2 million, or $0.09 per share, the year before.

Ford Motor Company (NYSE: F) sold widely Thursday, reporting volume in the early afternoon of 59,075,023 shares, compared to a full-day average of 69,745,000.  F shares stepped back 0.57 percent, though, to $16.55. Thursday, Ford Motor Co. Chief Executive Officer Alan Mulally said the company “deeply” appreciates the efforts by President Barack Obama and Ambassador Ron Kirk to negotiate a “meaningful” free trade agreement with Korea. Ford will continue to work closely with the Obama administration and Congress to fully open the Korean market to American-made cars and trucks.

Accretive Health Inc. (NYSE: AH) fared not so well in early Thursday afternoon trading, falling in price by 10.15 percent to $8.76. Volume in AH stock was 323,279 shares, compared to a daily average volume of 104,111 shares.  The Chicago-based company, which helps hospital systems manage their revenue cycles, said Thursday it turned a profit in the third quarter. AH said its net income totaled $2.9 million, or three cents per share. In the third quarter of 2009, the company distributed $8 million in dividends on preferred shares, and reported a loss of $3.8 million, or 11 cents per share. Its revenue rose 18 percent to $158.4 million from $134.5 million. However, analysts expected a profit of six cents per share and $172.4 million in revenue.

SPPH, MRES, IROG surge

Thursday, November 11th, 2010

Spencer Pharmaceutical Inc. (Pink Sheets: SPPH) surged 53.32 percent in price by noon ET Thursday to 42.9 cents. Volume was 4.35 million shares. The Boston-based company announced Thursday that an unsolicited offer received on November 4, 2010 is at a premium of $0.97 per share, making the potential transaction valued at $245 million. SPPH has opted to continue to keep the purchaser’s name confidential until such time as a timeline can be presented and the approval of the board of directors can be obtained.

NeuroBiotech Corp. (Pink Sheets: MRES) surged 40.91 percent by midday Thursday to a price of 3.1 cents, based on volume of 1,611,044 million shares. The company, based out of Basel, Switzerland, is currently actively working towards the commercialization of natural products called “Neuroceuticals®”, specially designed to restore the nervous system equilibrium and improve the state of health as well as the quality of life of people affected by stress-related disorders.

Ironwood Gold Corp. (OTCBB: IROG) picked up 3.45 percent in price by noon ET Thursday to 12 cents. Volume in the stock traded at 834, 580 shares. Wednesday, the Scottsdale, Ariz.-based junior miner announced favorable results of the Mobile Metal Ion (MMI) soil survey that was completed October 12 at its Rock Creek property in Nevada.